Wave Neuroscience Inc. has developed proprietary technology called Magnetic EEG/ECG-guided Resonant Therapy, or MeRT, as an innovative approach to identifying and treating brain conditions. Having completed more than 9 clinical trials, Wave Neuroscience Inc’s MeRT therapy is offered at 12 locations around the world. To date, more than 7,000 patients have been treated using the innovative method. Committed to empowering brain function as a means to improve quality of life, Wave Neuroscience has created a targeted therapy that improves conditions such as autism, PTSD, depression, and sports injury.

The process involves the administration of an electroencephalogram (q-EEG) and an electrocardiogram (EKG) to measure brainwave frequencies and heart rate. Then, the clinical and scientific teams analyze results and utilize this detailed neurophysiological data to create a treatment plan. An average MeRT course ranges from 4 to 6 weeks.

Wave Neuroscience works in partnership with government agencies such as the Department of Defense, as well as private institutions such as Cedars Sinai and Kerlan Jobe Sports Neurology.